Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. During the quarter the strategy returned 11.8% net of fees compared to the S&P 500’s 10.6% return. The outperformance of the portfolio can be attributed to selection and allocation effects, which are partially counteracted by interaction effects, according to a three-factor performance attribution model. In addition, you can check the top 5 holdings of the fund to know its best picks in 2024.
Patient Capital Opportunity Equity Strategy featured stocks like Expedia Group, Inc. (NASDAQ:EXPE) in the first quarter 2024 investor letter. Headquartered in Seattle, Washington, Expedia Group, Inc. (NASDAQ:EXPE) is an online travel company. On April 22, 2024, Expedia Group, Inc. (NASDAQ:EXPE) stock closed at $131.59 per share. One-month return of Expedia Group, Inc. (NASDAQ:EXPE) was -4.17%, and its…